Terashita Z et al. |
Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3004156
|
Archer CB et al. |
Actions of disodium cromoglycate (DSCG) on human skin responses to histamine, codeine and Paf-acether. |
1985 |
Agents Actions |
pmid:3923788
|
Morley J et al. |
Pharmacology of the late response to allergen and its relevance to asthma prophylaxis. |
1985 |
Int. Arch. Allergy Appl. Immunol. |
pmid:3924841
|
Hwang SB et al. |
Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. |
1985 |
Lab. Invest. |
pmid:3925239
|
Malone B et al. |
Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product. |
1985 |
J. Biol. Chem. |
pmid:3918041
|
Juhan-Vague I et al. |
Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro. |
1985 |
Thromb. Res. |
pmid:3923649
|
Steiner M et al. |
Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3936503
|
Vanderwel M and Haslam RJ |
Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate. |
1985 |
J. Clin. Invest. |
pmid:2991338
|
Naccache PH et al. |
Unique inhibitory profile of platelet activating factor induced calcium mobilization, polyphosphoinositide turnover and granule enzyme secretion in rabbit neutrophils towards pertussis toxin and phorbol ester. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2992480
|
MacIntyre DE et al. |
Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase C. |
1985 |
FEBS Lett. |
pmid:2993027
|
Bourgain RH et al. |
The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall. |
1985 |
Prostaglandins |
pmid:3931178
|
Hayashi H et al. |
Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists. |
1985 |
J. Biochem. |
pmid:2993272
|
Avdonin PV et al. |
Stimulation of high-affinity hormone-sensitive GTPase of human platelets by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphocholine (platelet activating factor). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2994653
|
Ribbes G et al. |
Evidence that biosynthesis of platelet-activating factor (paf-acether) by human neutrophils occurs in an intracellular membrane. |
1985 |
FEBS Lett. |
pmid:3932094
|
Maridonneau-Parini I et al. |
Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2994661
|
GarcÃa-Sáinz JA and Hernández-Sotomayor SM |
Stimulation of hepatic glycogenolysis by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) via cyclooxygenase products. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3933497
|
Zukowska-Grojec Z et al. |
The adrenergic system and the cardiovascular effects of platelet activating factor (1-0-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine) in SHR and WKY rats. |
1985 |
Clin Exp Hypertens A |
pmid:2994912
|
Shen TY et al. |
The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor. |
1985 |
Int J Tissue React |
pmid:2997065
|
Barnes PJ |
Mediators and asthma. |
1985 |
Br J Hosp Med |
pmid:3936563
|
Hemmendinger S et al. |
[Physiology of the interactions of blood and the blood vessel wall. Role of pharmacologically active lipids]. |
1985 |
Arch Mal Coeur Vaiss |
pmid:3938941
|
Tokumura A et al. |
Structural analogs of alkylacetylglycerophosphocholine inhibitory behavior on platelet activation. |
1985 |
J. Biol. Chem. |
pmid:3840169
|
Sánchez-Crespo M et al. |
Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether. |
1985 |
Immunopharmacology |
pmid:3840779
|
Foa R et al. |
Release of platelet-activating factor in human leukemia. |
1985 |
Cancer Res. |
pmid:3861246
|
Otsuka A et al. |
Hypotensive mechanism of acetyl glyceryl ether phosphorylcholine (AGEPC) in dogs. Effects on hemodynamics and humoral factors. |
1985 |
Prostaglandins Leukot Med |
pmid:3862138
|
Ostermann G et al. |
Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues. |
1985 |
Biomed. Biochim. Acta |
pmid:4004829
|
Emeis JJ and Kluft C |
PAF-acether-induced release of tissue-type plasminogen activator from vessel walls. |
1985 |
Blood |
pmid:3924144
|
Ardaillou N et al. |
Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells. |
1985 |
Am. J. Physiol. |
pmid:3918460
|
Pritchard PH et al. |
The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease). |
1985 |
Blood |
pmid:4063532
|
Cordón-Cardó C |
[The barley cell or mastocyte: cellular and molecular biology]. |
1985 |
Med Clin (Barc) |
pmid:2580196
|
McManus LM and Pinckard RN |
Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit. |
1985 |
Am. J. Pathol. |
pmid:4050977
|
Disselnkötter H et al. |
[Synthesis of phosphono analogs of 2-O-acetyl-1-O-hexadecyl(octadecyl)-sn-3-glycerylphosphorylcholine (platelet-activating factor)]. |
1985 |
Arch. Pharm. (Weinheim) |
pmid:4051690
|
Ogunbiyi PO and Eyre P |
Pharmacological studies of pulmonary anaphylaxis in vitro: a review. |
1985 |
Agents Actions |
pmid:2420161
|
Robinson M and Snyder F |
Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species. |
1985 |
Biochim. Biophys. Acta |
pmid:4052436
|
Kozlov VK et al. |
[Characteristics of the activation of rabbit platelets induced by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activation factor)]. |
1985 |
Biull Eksp Biol Med |
pmid:4052603
|
Page CP et al. |
Properties of PAF-acether appropriate to a mediator of the inflammatory aspects of asthma. |
1985 |
Int J Tissue React |
pmid:4055261
|
Wardlow ML |
Rapid isocratic procedure for the separation of platelet-activating factor from phospholipids in human saliva by high-performance liquid chromatography. |
1985 |
J. Chromatogr. |
pmid:4055961
|
Hubbard JW et al. |
Cardiac output and peripheral vascular resistance during intravenous infusion of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious normotensive and spontaneously hypertensive rats. |
1985 |
Res. Commun. Chem. Pathol. Pharmacol. |
pmid:4059660
|
Imbs AB et al. |
[Synthesis of a fluorescently-labeled platelet activating factor]. |
1985 |
Bioorg. Khim. |
pmid:4062993
|
Sugiura T et al. |
Transacylation of 1-O-alkyl-SN-glycero-3-phosphocholine (lyso platelet-activating factor) and 1-O-alkenyl-SN-glycero-3-phosphoethanolamine with docosahexaenoic acid (22:6 omega 3). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2935146
|
Tencé M et al. |
Ether-phospholipid composition in neutrophils and platelets. |
1985 |
Thromb. Res. |
pmid:4024039
|
Tan EL and Snyder F |
Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by capillary endothelial cells isolated from rat epididymal adipose tissue. |
1985 |
Thromb. Res. |
pmid:4024051
|
Vigo C |
Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization. |
1985 |
J. Biol. Chem. |
pmid:3919022
|
Morley J et al. |
PAF and airway hyperreactivity. |
1985 |
Lancet |
pmid:2863479
|
Armstrong RA et al. |
Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha. |
1985 |
Prostaglandins |
pmid:2988022
|
Sugiura T and Waku K |
CoA-independent transfer of arachidonic acid from 1,2-diacyl-sn-glycero-3-phosphocholine to 1-O-alkyl-sn-glycero-3-phosphocholine (lyso platelet-activating factor) by macrophage microsomes. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3919727
|
Dewald B and Baggiolini M |
Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2985075
|
Wasserman SI |
The mast cell and theophylline in asthma. |
1985 |
Am. J. Med. |
pmid:3002176
|
Orlov SM et al. |
[Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs]. |
1985 |
Biokhimiia |
pmid:2408682
|
Hallam TJ and Rink TJ |
Agonists stimulate divalent cation channels in the plasma membrane of human platelets. |
1985 |
FEBS Lett. |
pmid:2408921
|
Tou J |
Platelet-activating factor promotes arachidonate incorporation into phosphatidylinositol and phosphatidylcholine in neutrophils. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3921017
|